Clinical Trial Update: PHArmaCokinetics of methYLphenidate in Adult Patients With Attention-Deficit /Hyperactivity Disorder [Phase 4]

View source ↗

Summary

Phase 4 pharmacokinetics study of methylphenidate in adults with ADHD is not yet recruiting; obesity is listed as an inclusion condition in the trial listing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder
• Obesity

Drugs mentioned

• Methylphenidate (Methylphenidate)

Snippet

Sponsor: University Hospital, Tours | Conditions: Attention Deficit Hyperactivity Disorder (ADHD), Obesity (Body Mass Index &Amp;Amp;gt;30 kg/m2) | Phase 4 | Status: NOT_YET_RECRUITING